SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-185733
Filing Date
2017-05-26
Accepted
2017-05-26 17:01:57
Documents
5
Period of Report
2017-05-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d261905d8k.htm 8-K 15812
2 EX-1.1 d261905dex11.htm EX-1.1 162228
3 EX-5.1 d261905dex51.htm EX-5.1 8396
4 GRAPHIC g261905morganlewisaddress1.jpg GRAPHIC 11295
5 GRAPHIC g261905morganlewislogo2.jpg GRAPHIC 3924
  Complete submission text file 0001193125-17-185733.txt   203605
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 17874750
SIC: 2836 Biological Products, (No Diagnostic Substances)